Inventor · disambiguated record
Corinna Maul
Also filed as: MAUL CORINNA
22 granted patents·3 pending applications·149 citations·filing 2000–2011
94Inventor score
Technology areasA61P
Top patents by PatentIndex Score
25 records- 0189US6638933B2Bicyclic imidazo-3-yl-amine derivativesGRUENENTHAL GMBH·Filed 2002·Granted Oct 28, 2003·40 cites·12 claims
- 0287US6657064B2Bicyclic imidazo-5-yl-amine derivativesGRUENENTHAL GMBH·Filed 2002·Granted Dec 2, 2003·26 cites·18 claims
- 0383US8048890B2Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives and related treatment methodsGRUENENTHAL GMBH·Filed 2003·Granted Nov 1, 2011·22 cites·44 claims
- 0478US6797712B2Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and painGRUENENTHAL GMBH·Filed 2003·Granted Sep 28, 2004·12 cites·20 claims
- 0578US6703404B2Tert -butyl-(7-methyl-imidazol [1,2-a]pyridin-3-yl)-amine derivativesGRUENENTHAL GMBH·Filed 2002·Granted Mar 9, 2004·11 cites·21 claims
- 0674US7022739B2Substituted 1-aminobutan-3-ol compoundsGRUENENTHAL GMBH·Filed 2003·Granted Apr 4, 2006·7 cites·34 claims
- 0774US6849642B2Bicyclic imidazo-3-yl-amine derivatives substituted on the 6-membered ringGRUENENTHAL GMBH·Filed 2002·Granted Feb 1, 2005·8 cites·13 claims
- 0872US6936631B2Bicyclic imidazo-5-yl-amine derivativesGRUENENTHAL GMBH·Filed 2003·Granted Aug 30, 2005·5 cites·18 claims
- 0971US6699877B2Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivativesGRUENENTHAL GMBH·Filed 2002·Granted Mar 2, 2004·7 cites·62 claims
- 1067US7091220B2Substituted indole Mannich basesGRUENENTHAL GMBH·Filed 2000·Granted Aug 15, 2006·3 cites·98 claims
- 1167US7034018B2Substituted pyrrole mannich bases to combat pain and allergic reactionsGRUENENTHAL GMBH·Filed 2000·Granted Apr 25, 2006·3 cites·93 claims
- 1266US7273952B2Substituted C-cyclohexylmethylamine derivativesGRUENENTHAL GMBH·Filed 2003·Granted Sep 25, 2007·3 cites·56 claims
- 1365US6774136B2Substituted 1 and 2 naphthol mannich basesGRUENENTHAL GMBH·Filed 2000·Granted Aug 10, 2004·2 cites·113 claims
- 1452US7202242B2Substituted 1 and 2-naphthol Mannich basesGRUENENTHAL GMBH·Filed 2004·Granted Apr 10, 2007·0 cites·113 claims
- 1547US2003225084A1Sulfonylguanidine compounds and pharmaceutical uses thereofGRUENENTHAL GMBH·Filed 2003·Application pending·0 cites
- 1646US7569585B21, 5-diaminopentan-3-ol compounds and related treatment methodsGRUENENTHAL GMBH·Filed 2004·Granted Aug 4, 2009·0 cites·17 claims
- 1746US7507816B2Pharmaceutical preparations comprising substituted beta-aminoalcoholsGRUENENTHAL GMBH·Filed 2004·Granted Mar 24, 2009·0 cites·20 claims
- 1845US2004122044A1Utilization of substituted imidazo [1,2-A]-pyridin-3-yl-amide and imidazo [1,2-A]-pyridin-3-yl-amine compounds in pharmaceutical formulationsFiled 2003·Application pending·0 cites
- 1944US7199130B2Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonistsGRUENENTHAL GMBH·Filed 2004·Granted Apr 3, 2007·0 cites·49 claims
- 2044US2004023972A1Use of substituted imidazo[1,2-a]-pyridin-, -pyrimidin-and-pyrazin-3-yl-amine derivatives in the preparation of medicaments for inhibiting NOSGRUENENTHAL GMBH·Filed 2003·Application pending·0 cites
- 2143US7230103B2Substituted 3,4-dihydropyrido[1,2-a]pyrimidinesGRUENENTHAL GMBH·Filed 2003·Granted Jun 12, 2007·0 cites·14 claims
- 2243US7226924B2Substituted 3,4-dihydro-pyrimido[1,2a]pyrimidines and 3,4-dihydro-pyrazino[1,2a]pyrimidines, and methods for their preparation and useGRUENENTHAL GMBH·Filed 2003·Granted Jun 5, 2007·0 cites·18 claims
- 2343US6815443B25-Amino-1-pentene-3-ol substituted derivativesGRUENENTHAL GMBH·Filed 2003·Granted Nov 9, 2004·0 cites·34 claims
- 2442US7816358B2Pharmaceutical formulations comprising N,N′-disubstituted piperazine compoundsGRUENENTHAL GMBH·Filed 2004·Granted Oct 19, 2010·0 cites·15 claims
- 2536US8557796B2Substituted 1-oxa-2,8-diaza-spiro [4,5] dec-2-ene derivatives and related treatment methodsBUSCHMANN HEINRICH HELMUT·Filed 2011·Granted Oct 15, 2013·0 cites·38 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →